1. Cardiac Transplantation in Pediatric Patients: Fifteen-Year Experience of a Single Center 
Jan Groetzner, MD, Bruno Reichart, MD, Ulrich Roemer, MD, Stefanie Reichel, MD, Rainer Kozlik-Feldmann, MD, Andreas Tiete, MD, Joerg Sachweh, MD, Heinrich Netz, MD, Sabine Daebritz, MD 
The Annals of Thoracic Surgery 
Volume 79, Issue 1, Pages (January 2005)
DOI: /j.athoracsur

2. Fig 1
Kaplan-Meier cumulative survival of patients with dilated cardiomyopathy (DCM) compared to patients with congenital heart disease (CHD) in percentages. Black line = all patients; grey bars = CHD patients (n = 17); grey dots = DCM patients (n = 30).
The Annals of Thoracic Surgery  , 53-60DOI: ( /j.athoracsur )

3. Fig 2
Kaplan-Meier cumulative survival of patients transplanted between 1988 and 1995 compared to patients transplanted between 1996 and 2002 in percentages. Grey bars = HTx 1996 to 2002 (n = 26); – – = HTx 1988 to 1995 (n = 24). (HTx = heart transplantation.)
The Annals of Thoracic Surgery  , 53-60DOI: ( /j.athoracsur )

4. Fig 3
Actuarial freedom from acute rejection (AR) dependent on immunosuppressive regimen. (Mycophenolate mofetil [MMF] and cyclosporine or tacrolimus [black bar; n = 27] versus azathioprine or steroids and cyclosporine or tacrolimus [grey bar; n = 23].) (Aza = azathioprin.)
The Annals of Thoracic Surgery  , 53-60DOI: ( /j.athoracsur )

5. Fig 4
Incidence and spectrum (bacterial [light grey box], fungal [white box], viral [dark grey box]) of infections depending on the primary immunosuppressant (cyclosporine [CsA] versus tacrolimus [Tac]) shown as number of infections per 100 survived patient days.
The Annals of Thoracic Surgery  , 53-60DOI: ( /j.athoracsur )

6. Fig 5
Serum creatinine in mg/dL as a marker of renal function: preoperatively, at discharge, at the recent follow-up depending on the primary immunosuppressant agent. Light grey box = tacrolimus patients; dark grey box = cyclosporine patients.
The Annals of Thoracic Surgery  , 53-60DOI: ( /j.athoracsur )